Specific tamoxifen-induced MyD88 deletion in intestinal epithelial cells protects against diet-induced obesity, is associated with increased energy expenditure, improves glucose homeostasis, and reduces hepatic steatosis and whole-body fat mass by 30 %. The gene discussed is MYD88; the disease is obesity due to melanocortin 4 receptor deficiency.